Helmut Schaider

4.3k total citations
82 papers, 2.9k citations indexed

About

Helmut Schaider is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Helmut Schaider has authored 82 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 38 papers in Molecular Biology and 21 papers in Immunology. Recurrent topics in Helmut Schaider's work include Cutaneous Melanoma Detection and Management (20 papers), Immunotherapy and Immune Responses (12 papers) and Melanoma and MAPK Pathways (10 papers). Helmut Schaider is often cited by papers focused on Cutaneous Melanoma Detection and Management (20 papers), Immunotherapy and Immune Responses (12 papers) and Melanoma and MAPK Pathways (10 papers). Helmut Schaider collaborates with scholars based in Australia, Austria and United States. Helmut Schaider's co-authors include Meenhard Herlyn, Mark E. Nesbit, Beate Rinner, Kapaettu Satyamoorthy, Heinz Hammerlindl, H. Peter Soyer, Dagmar Zweytick, Sabrina Riedl, Karl Lohner and Carola Berking and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Helmut Schaider

80 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helmut Schaider Australia	31	1.5k	1.1k	731	353	250	82	2.9k
Oliver Dorigo United States	28	971 0.7×	710 0.7×	473 0.6×	205 0.6×	228 0.9×	89	2.2k
Sophia N. Karagiannis United Kingdom	37	1.2k 0.8×	1.3k 1.2×	1.8k 2.5×	234 0.7×	225 0.9×	127	4.0k
Anna Mandinova United States	31	2.5k 1.8×	1.0k 1.0×	539 0.7×	531 1.5×	507 2.0×	61	3.9k
Jens Oliver Funk Germany	28	1.2k 0.9×	926 0.9×	450 0.6×	245 0.7×	186 0.7×	44	2.7k
Rossitza Lazova United States	28	886 0.6×	760 0.7×	393 0.5×	243 0.7×	294 1.2×	91	2.3k
Pavel Gromov Denmark	32	1.9k 1.3×	566 0.5×	378 0.5×	537 1.5×	214 0.9×	78	2.9k
Wolfram E. Samlowski United States	34	1.5k 1.0×	1.6k 1.5×	848 1.2×	349 1.0×	143 0.6×	154	3.7k
Judith P. Johnson Germany	31	1.8k 1.2×	1.0k 1.0×	1.3k 1.8×	367 1.0×	462 1.8×	67	3.6k
Haiming Dai China	27	1.7k 1.2×	478 0.4×	522 0.7×	364 1.0×	151 0.6×	62	2.7k
Amalia Azzariti Italy	37	1.9k 1.3×	1.4k 1.3×	334 0.5×	601 1.7×	229 0.9×	132	3.6k

Countries citing papers authored by Helmut Schaider

Since Specialization

Citations

This map shows the geographic impact of Helmut Schaider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helmut Schaider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helmut Schaider more than expected).

Fields of papers citing papers by Helmut Schaider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helmut Schaider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helmut Schaider. The network helps show where Helmut Schaider may publish in the future.

Co-authorship network of co-authors of Helmut Schaider

This figure shows the co-authorship network connecting the top 25 collaborators of Helmut Schaider. A scholar is included among the top collaborators of Helmut Schaider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helmut Schaider. Helmut Schaider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ladwa, Rahul, James Monkman, Caroline Cooper, et al.. (2023). 1144P High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study. Annals of Oncology. 34. S685–S685.

Soyer, H. Peter, Caitlin Horsham, Helmut Schaider, et al.. (2023). Skin Cancer Excisions and Histopathology Outcomes When Following a Contemporary Population-Based Cohort Longitudinally with 3D Total-Body Photography. SHILAP Revista de lepidopterología. 3(2). e216–e216. 3 indexed citations

Horsham, Caitlin, Adèle C. Green, Helmut Schaider, et al.. (2022). The Experience of 3D Total-Body Photography to Monitor Nevi: Results From an Australian General Population-Based Cohort Study. JMIR Dermatology. 5(2). e37034–e37034. 9 indexed citations

Bergman, Drew T., Lucas A. Salas, Duncan Lambie, et al.. (2021). Genome-Scale DNA Methylation Analysis Identifies Repeat Element Alterations that Modulate the Genomic Stability of Melanocytic Nevi. Journal of Investigative Dermatology. 142(7). 1893–1902.e7. 10 indexed citations

Wang, Jing, Alain Wuethrich, Mitchell Stark, et al.. (2021). An Integrated Microfluidic‐SERS Platform Enables Sensitive Phenotyping of Serum Extracellular Vesicles in Early Stage Melanomas. Advanced Functional Materials. 32(3). 65 indexed citations

Duffy, David L., Darren J. Smit, Kasturee Jagirdar, et al.. (2020). Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants. PLoS ONE. 15(9). e0238529–e0238529. 12 indexed citations

Joseph, Shannon R., Rachael Barry, Blerida Banushi, et al.. (2018). An Ex Vivo Human Tumor Assay Shows Distinct Patterns of EGFR Trafficking in Squamous Cell Carcinoma Correlating to Therapeutic Outcomes. Journal of Investigative Dermatology. 139(1). 213–223. 17 indexed citations

Janda, Monika, Joanne F. Aitken, David L. Duffy, et al.. (2018). ‘Mind your Moles’ study: protocol of a prospective cohort study of melanocytic naevi. BMJ Open. 8(9). e025857–e025857. 19 indexed citations

Hammerlindl, Heinz, Dinoop Ravindran Menon, Abdullah Al Emran, et al.. (2017). Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS -Mutant Cancers. Clinical Cancer Research. 24(5). 1090–1102. 15 indexed citations

10.

Thomas, Janine, et al.. (2017). Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases—a phase II, single centre, randomised, pilot study. BMJ Open. 7(10). e016816–e016816. 14 indexed citations

11.

Aberer, Elisabeth, et al.. (2017). Co-culture of human fibroblasts and Borrelia burgdorferi enhances collagen and growth factor mRNA. Archives of Dermatological Research. 310(2). 117–126. 8 indexed citations

12.

Rad, Ehsan Bonyadi, Heinz Hammerlindl, Dinoop Ravindran Menon, et al.. (2016). Notch4 Signaling Induces a Mesenchymal–Epithelial–like Transition in Melanoma Cells to Suppress Malignant Behaviors. Cancer Research. 76(7). 1690–1697. 44 indexed citations

13.

Riedl, Sabrina, Beate Rinner, Helmut Schaider, Karl Lohner, & Dagmar Zweytick. (2014). Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine. BioMetals. 27(5). 981–997. 36 indexed citations

14.

Deutsch, Alexander, Nicole Hofmann, Dirk Strunk, et al.. (2012). Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma. Modern Pathology. 26(2). 182–194. 59 indexed citations

15.

Riedl, Sabrina, et al.. (2011). Targeting the cancer cell membrane specifically with human lactoferricin derivatives. Annals of Oncology. 22. 33–33. 7 indexed citations

16.

Bergler, Helmut, et al.. (2011). Transcriptional Activation of ZEB1 by Slug Leads to Cooperative Regulation of the Epithelial–Mesenchymal Transition-Like Phenotype in Melanoma. Journal of Investigative Dermatology. 131(9). 1877–1885. 124 indexed citations

17.

Gutwein, Paul, Anja Schramme, Mohamed S. Abdel‐Bakky, et al.. (2008). Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. European Journal of Cancer. 45(3). 478–489. 81 indexed citations

18.

Schaider, Helmut, et al.. (2007). A signaling mute hCMV chemokine receptor prevents melanoma growth. Experimental Dermatology. 16(3). 262–263. 1 indexed citations

19.

Schaider, Helmut, et al.. (2006). The signaling mute hCMV chemokine receptor US28R129A prevents melanoma growth. Pharmacology. 78(3). 149–149. 1 indexed citations

20.

Oka, Masahiro, Carola Berking, Mark E. Nesbit, et al.. (2000). Interleukin-8 Overexpression Is Present in Pyoderma Gangrenosum Ulcers and Leads to Ulcer Formation in Human Skin Xenografts. Laboratory Investigation. 80(4). 595–604. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact